Foreign-affiliated pharmaceutical manufacturers have announced their settlements of accounts for 2011. Though deteriorating healthcare finances are putting growing pressure on drug prices worldwide, these companies recorded double-digit growth in sales in Japan as well as in newly emerging markets. The…
To read the full story
Related Article
- The Growing Presence of Foreign-Affiliates (3)
May 21, 2012
- The Growing Presence of Foreign-Affiliates (2)
May 14, 2012
BUSINESS
- Gilead Files CAR-T Therapy Tecartus in Japan for MCL, B-ALL
August 21, 2026
- Tiger, Gaudi Develop Compact Cell Transport Container
August 21, 2026
- Sawai’s Solo Tenelia Copy Raises Patent Questions Ahead of December Listing
August 21, 2026
- DT-Axis Charts Path to 2nd-Stage DTx Approval with Depression App
August 21, 2026
- Amvuttra Key to Alnylam Japan’s 25%-Plus CAGR Goal through 2030
August 20, 2026
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…





